Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 USD | +2.68% | -2.13% | +76.92% |
Jun. 04 | LadRx Corporation and ImmunityBio, Inc. Mutually Agree to Terminate Aldoxorubicin License | CI |
May. 15 | LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- LADX Stock
- News LadRx Corporation
- MarketScreener Strategies